Published in Int Pharmacopsychiatry on January 01, 1977
The history of the psychopharmacology of schizophrenia. Can J Psychiatry (1997) 2.64
Yawning. A homeostatic reflex and its psychological significance. Bull Menninger Clin (1979) 2.16
Adynamic ileus during psychoactive medication: a report of three fatal and five severe cases. Can Med Assoc J (1967) 1.40
Dose equivalent for haloperidol and phenothiazines. Can Med Assoc J (1967) 1.38
Phenothiazines alone and in combination. Appl Ther (1966) 1.14
Side effects and teratogenicity of lithium carbonate treatment. J Clin Pharmacol J New Drugs (1970) 1.12
Ethanol specifically potentiates GABA-mediated neurotransmission in feline cerebral cortex. Science (1980) 1.08
Chemical reduction of the compulsion to drink with metronidazole: a new treatment modality in the therapeutic program of the alcoholic. Curr Ther Res Clin Exp (1967) 1.07
Toxic psychotic syndrome associated with chlorpromazine administration. Can Med Assoc J (1970) 1.07
Neuroleptic-induced skin pigmentation in chronic hospitalized schizophrenic patients. Can J Psychiatry (1985) 0.99
A clinical trial with nomifensin, a new antidepressant drug. Int J Clin Pharmacol Biopharm (1975) 0.98
Clinical studies with propericiazine (R.P. 8909). Dis Nerv Syst (1967) 0.96
Diazepam in high doses is effective in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (1982) 0.93
A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression. Psychopharmacol Bull (1984) 0.93
Beta-endorphin--induced changes in schizophrenic and depressed patients. Arch Gen Psychiatry (1977) 0.91
The philosophy of long-acting medication in psychiatry. Dis Nerv Syst (1970) 0.91
Interaction of indomethacin and ibuprofen with lithium in manic patients under a steady-state lithium level. J Clin Psychiatry (1980) 0.90
DCR Budapest-Nashville in the diagnosis and classification of functional psychoses. Psychopathology (1988) 0.90
Metronidazole in the treatment of the alcoholic. Psychiatr Neurol (Basel) (1966) 0.90
A comparison of the hypnotic properties of mandrax and its two constituents. Curr Ther Res Clin Exp (1968) 0.90
Description and distribution of the subtypes of chronic schizophrenia based on Leonhard's classification. Psychiatr Dev (1984) 0.88
Clinical pharmacology of the tricyclic antidepressants. Appl Ther (1966) 0.88
Therapy of Phenothiazine-produced skin pigmentation: a preliminary report. Am J Psychiatry (1966) 0.88
International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders. J Clin Psychopharmacol (1999) 0.86
Flexible system criteria in chronic schizophrenia. Compr Psychiatry (1986) 0.85
Viloxazine in the treatment of depressive neurosis: a controlled clinical study with doxepin and placebo. Br J Psychiatry (1980) 0.84
Factors related to tardive dyskinesia. Am J Psychiatry (1979) 0.84
The AMDP-system in chronic hospitalized schizophrenics. Compr Psychiatry (1985) 0.84
Clobazam: uncontrolled and standard controlled clinical trials. Br J Clin Pharmacol (1979) 0.84
The effect of hypnotics on rapid eye movement (REM). Int Z Klin Pharmakol Ther Toxikol (1968) 0.84
Audiologic and psychological profile of Greek patients with tinnitus--preliminary findings. Am J Otolaryngol (2001) 0.83
Systematic clinical studies with trazodone: methodological aspects. Curr Ther Res Clin Exp (1973) 0.83
Neurotoxicity with combined administration of lithium and a neuroleptic. Compr Psychiatry (1983) 0.83
The treatment of depressed geriatric patients. Am J Psychother (1978) 0.83
Possible lack of anticholinergic effects with mianserin: a pilot study. J Clin Psychiatry (1980) 0.83
International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997. Depress Anxiety (1999) 0.82
Neurological side effects of lithium: organic brain syndrome, seizures, extrapyramidal side effects, and EEG changes. Compr Psychiatry (1980) 0.82
Effect of withdrawal of antiparkinsonian medication on chronically hospitalized psychiatric patients. Laval Med (1970) 0.82
Levels of anxiety and depression in spinal cord-injured patients. Psychosomatics (1982) 0.82
Negative findings with nicotinic acid in the treatment of schizophrenias. Int Pharmacopsychiatry (1974) 0.81
The future of psychiatry: progress--mutation--or self destruct? Can J Psychiatry (1986) 0.81
Nicotinic acid in the treatment of schizophrenias. Canadian Mental Health Association collaborative study: progress report II. Can Psychiatr Assoc J (1975) 0.81
A double-blind placebo-controlled study to compare the autonomic effects of fluvoxamine with those of amitriptyline and doxepin in healthy volunteers. Br J Clin Pharmacol (1983) 0.81
High doses of diazepam improve neuroleptic-resistant chronic schizophrenic patients. Psychopharmacology (Berl) (1983) 0.81
Propranolol in organic agitation. Lancet (1981) 0.80
Systematic studies with amoxapine, a new antidepressant. Int Pharmacopsychiatry (1982) 0.80
Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997. Eur Neuropsychopharmacol (1999) 0.80
Sexual behavior of the male schizophrenic: the impact of illness and medications. Arch Sex Behav (1981) 0.80
Research methodology and the pharmacotherapy of the chronic schizophrenias. Psychopharmacol Bull (1986) 0.79
Organic problems in the aged: brain syndromes and alcoholism: psychiatric aspects of the organic brain syndrome and pharmacological approaches to treatment. J Geriatr Psychiatry (1978) 0.79
Psychopharmacology and Leonhard's classification of chronic schizophrenias. Int Pharmacopsychiatry (1982) 0.79
Orienting-reflex behavior and clinical psychopathology. Cond Reflex (1969) 0.79
Rapid tranquilization: a comparative study of thiothixene and haloperidol. Prog Neuropsychopharmacol Biol Psychiatry (1984) 0.78
Parkinsonism induced by high doses of diazepam. Biol Psychiatry (1985) 0.78
Viloxazine in the treatment of endogenous depression. A standard (amitriptyline) controlled clinical study. Int Pharmacopsychiatry (1982) 0.78
An international survey of tardive dyskinesia. Prog Neuropsychopharmacol Biol Psychiatry (1985) 0.78
Lack of indication for use of antiparkinson medication. A follow-up study. Dis Nerv Syst (1971) 0.78
Acute psychosis precipitated by withdrawal of anticonvulsant medication. Am J Psychiatry (1978) 0.78
The place of doxepin among the anxiolytic-sedative drugs. Curr Ther Res Clin Exp (1972) 0.78
International study of expert judgement on therapeutic use of benzodiazepines and other psychotherapeutic medications: II. Pharmacotherapy of anxiety disorders. J Affect Disord (1995) 0.78
Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics. Can Psychiatr Assoc J (1973) 0.78
Psychotropic drug prescription pattern in a developing country (Nigeria). The need for an essential psychotherapeutic drug list. Int Pharmacopsychiatry (1982) 0.78
Negative findings with megavitamins in schizophrenic patients: preliminary report. Commun Psychopharmacol (1977) 0.78
Vitamins in psychiatry. Do they have a role? Drugs (1985) 0.78
Pharmacotherapy of chronic hospitalized schizophrenics: prescription practices. Neuropsychobiology (1985) 0.78
Neurotoxicity in patients with schizophrenia during lithium therapy. Compr Psychiatry (1982) 0.77
Cholecystokinin appears to have antipsychotic properties. Prog Neuropsychopharmacol Biol Psychiatry (1982) 0.77
Clinical evaluation and natural course of depression. J Clin Psychiatry (1983) 0.77
Ethanol selectively potentiates GABA-mediated inhibition of single feline cortical neurons. Life Sci (1980) 0.77
Glycosaminoglycan polysulfate (Ateroid) in old-age dementias: effects upon depressive symptomatology in geriatric patients. Prog Neuropsychopharmacol Biol Psychiatry (1989) 0.77
Problems of differential diagnosis and choice of therapy in depressive states. Psychosomatics (1965) 0.77
Chronic schizophrenias: a guide to Leonhard's classification. Compr Psychiatry (1982) 0.77
Gabaergic mechanisms and anxiety: an overview and a new neurophysiological model. Can J Psychiatry (1984) 0.76
Benzodiazepine and gaba receptors are functionally related: further electrophysiological evidence in vivo. Prog Neuropsychopharmacol Biol Psychiatry (1982) 0.76
Pharmacotherapy of tension and anxiety. Curr Psychiatr Ther (1972) 0.76
Nicotinic acid in the prevention and treatment of methionine-induced exacerbation of psychopathology in schizophrenics. Can Psychiatr Assoc J (1970) 0.76
A survey of extrapyramidal manifestations in the inpatient population of a psychiatric hospital. Laval Med (1970) 0.76
Acquired transient CNS hypersensitivity to lithium therapy. Can J Psychiatry (1980) 0.76
Doxepin in the treatment of psychoneurotic patients. Curr Ther Res Clin Exp (1970) 0.76
A comparative evaluation of doxepin and chlordiazepoxide in the treatment of psychoneurotic outpatients. Curr Ther Res Clin Exp (1970) 0.76